Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 3702-3708

  Johnson, Aaron J ^a   Njenga, M Kariuki ^a   Hansen, Michael J ^a   Kuhns, Scott T ^a   Chen, Lieping ^a   Rodriguez, Moses ^a   Pease, Larry R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL KILLING; CERVICAL LYMPH NODE; CYTOTOXIC T LYMPHOCYTE; GENE FREQUENCY; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MEDIATOR RELEASE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL;

EID: 0032899121     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.3702-3708.1999     Document Type: Article

References (53)

1. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
2. Azoulay, A., M. Brahic, and J. F. Bureau. 1994. FVB mice transgenic for the H-2D gene become resistant to persistent infection by Theiler's virus. J. Virol. 68:4049-4052.
3. Baldwin, A. S. 1996. The NF-kB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
4. Boehm, U., T. Klamp. M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749-795.
5. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71:5244-5250.
6. Bradl, M., and C. Linington. 1996. Animal models of demyelination. Brain Pathol. 6:303-311.
7. + CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J. Immunol. 157:505-511.
8. Chen, H., W. Kong, L. Ziang, P. L. Ward, and R. P. Roos. 1995. A picornavirus protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat. Med. 1: 927-931.
9. Cole, G. A., T. L. Hogg, and D. L. Woodland. 1994. The MHC class I-re-stricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767-1775.
10. Deng, Y., J. W. Yewdell, L. C. Eisenlohr, and J. R. Bennink. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507-1515.
11. Dethlefs, S., N. Escriou, M. Brahic, S. van der Werf, and E. L. Larsson-Sciard. 1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 71:5361-5365.
12. Drescher, K. M., L. R. Pease, and M. Rodriguez. 1997. Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol. Rev. 159:177-193.
13. Fiett, L., C. Aubert, M. Brahic, and C. P. Rossi. 1993. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:589-592.
14. Fiette, L., M. Brahic, and C. Pena-Rossi. 1996. Infection of class-II deficient mice by the DA strain of Theiler's virus. J. Virol. 70:4811-4815.
15. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89:3429-3433.
16. Gournier, H., S. Pocolo, C. A. Siegrist, J. Jehan, B. Peranau, Z. Garcia, T. Rose, J. Neefjes, and F. A. Lemonnier. 1995. Restriction of self-antigen presentation to cytolytic T lymphocytes by mouse peptide pumps. Eur. J. Immunol. 25:2019-2026.
17. Horwitz, M. S., Y. Yanagi, and M. B. A. Oldstone. 1993. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity. J. Virol. 68:352-357.
18. Larsson-Sciard, E. L., S. Dethlefs, and M. Brahic. 1997. In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence. J. Virol. 71:797-799.
19. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
20. Levitsky, V., Q.-J. Zhang, J. Levitskaya, and M. G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183:915-926.
21. Lin, X., L. R. Pease, and M. Rodriguez. 1997. Differential generation of class I H-2D-versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 27:963-970.
22. Lin, X., L. R. Pease, P. D. Murray, and M. Rodriguez. 1998. Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. J. Immunol. 160:5661-5668.
23. Lin, X., R. P. Roos. L. R. Pease, P. Wettstein, and M. Rodriguez. 1999. A Theiler's virus alternatively-initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. J. Immunol. 162:17-24.
24. Lindsley, M. D., and M. Rodriguez. 1989. Characterization of the inflammatory response in the central nervous system of mice susceptible to demyelination by Theiler's virus. J. Immunol. 142:2677-2682.
25. Melero, I., M. C. Singhal, P. McGowan, H. S. Haugen, J. Blake, K. E. Hellstrom, G. Yang, C. H. Clegg, and L. Chen. 1997. Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16. J. Virol. 71:3998-4004.
26. Miller, S. D., and W. J. Karpus. 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today 16:356-361.
27. Monteyne, P., J. F. Bureau, and M. Brahic. 1997. The infection of mouse by Theiler's virus: from genetics to immunology. Immunol. Rev. 159:163-176.
28. Moss, P. A. H., R. J. Moots, W. M. C. Rosenberg, S. J. Rowland-Jones, H. C. Bodmer, A. J. McMichael, and J. I. Bell. 1991. Extensive conservation of α and β chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 88:8987-8990.
29. Moudgil, K. M., D. S. Sekiguchi, S. Y. Kim, and E. E. Sercarz. 1997. Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen. J. Immunol. 159:2574-2579.
30. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. D. Sourdive, A. J. Zajac, J. D. Miller, J. Slasky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
31. + T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 72:7320-7329.
32. Murray, P. D., D. B. McGavern, X. Lin, M. K. Njenga, J. Leibowitz, L. R. Pease, and M. Rodriguez. 1998. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18:7306-7314.
33. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289-299.
34. Njenga, M. K., K. D. Pavelko, J. Baisch. W. Lin, C. David, J. Leibowitz, and M. Rodriguez. 1996. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1729-1737.
35. Njenga, M. K., K. Asakura, S. F. Hunter, P. Wettstein, L. R. Pease, and M. Rodriguez. 1997. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 71:8592-8601.
36. Paya, C. V., A. Patick, P. J. Leibson, and M. Rodriguez. 1989. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143:95-102.
37. Pullen, L. C., S. D. Miller, M. Dal Canto, and B. S. Kim. 1993. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287-2293.
38. d transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1: 111-117.
39. Rodriguez, M., and S. Subramaniam. 1988. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 anti-body. J. Immunol. 140:2950-2955.
40. 2-microglobulin. J. Immunol. 151: 266-276.
41. Rodriguez, M., and C. David. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145-2148.
42. Rodriguez, M., J. Leibowitz, and C. S. David. 1986. Susceptibility to Theiler's virus-induced demyelination: mapping of the gene within the H-2D region. J. Exp. Med. 163:620-631.
43. Rodriguez, M., K. D. Pavelko, M. K. Njenga, W. C. Logan, and P. J. Wettstein. 1996. The balance between persistent virus infection and immune cells determines demyelination. J. Immunol. 157:5699-5709.
44. Rodriguez, M., L. R. Pease, and C. S. David. 1986. Immune-mediated injury of virus-infected oligodendrocytes. Immunol. Today 7:359-363.
45. Rossi, C. P., A. McAllister, M. Tanguy, D. Kagi, and M. Brahic. 1998. Theiler's virus infection of perforin-deficient mice. J. Virol. 72:4515-4519.
46. Sette, A., A. Vltiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M. del Guercio, S. Southwood, R. T. Kubo, R. W. Chestnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class 1 binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
47. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation, and function of NF-kB. Annu. Rev. Cell Biol. 10:405-455.
48. Stohlman, S. A., S. Kyuwa, J. M. Polo, D. Brady. M. M. D. Lai, and C. C. Bergmann. 1993. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J. Virol. 67:7050-7059.
49. Tallquist, M. D., T. J. Yun, and L. R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med.
50. Van den Burg, S. H., M. J. W. Visserea, R. M. P. Brandt, W. M. Kast, and C. J. M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156: 3308-3314.
51. Van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Murali-Krishna, L. L. Lau, S. Southwood, J. Sidney, R. W. Chesnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and sub-dominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543-5554.
52. Viner, N. J., C. A. Nelson, and E. R. Unanue. 1995. Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitation of lymph node proliferation studies in defining immunodominance and crypticity. Proc. Natl. Acad. Sci. USA 92:2214-2218.
53. Yellen-Shaw, A. J., E. J. Wherry, G. C. Dubois, and L. C. Eisenlohr. 1997. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:3227-3234.